Zhang L, Jin D, Zang J, Qian L, et al. Disitamab vedotin combined with toripalimab and radiotherapy for multimodal organ-sparing treatment of muscle invasive bladder cancer: a proof-of-concept study. Neoplasia 2025;68:101216.
PMID: 40774226